NCT04949464 is a NA clinical trial of Computed Tomography in HIV Infection, sponsored by AIDS Malignancy Consortium.

Who is sponsoring NCT04949464?

NCT04949464 is sponsored by AIDS Malignancy Consortium.

What drugs are being tested in NCT04949464?

Interventions in NCT04949464: Computed Tomography, Smoking Cessation Intervention.

What condition does NCT04949464 study?

NCT04949464 studies HIV Infection, Tobacco-Related Carcinoma.

Is NCT04949464 still recruiting?

NCT04949464 is currently recruiting now. Last updated 23 January 2026.

Last reviewed 2026-01-23 · How we verify

NCT04949464

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

Recruiting now NA Last updated 23 January 2026

What this trial tests

NA trial testing Computed Tomography in HIV Infection in 100 participants. Currently enrolling.

Timeline

22 March 2023

Primary endpoint
30 May 2026

31 March 2027

Quick facts

Lead sponsor	AIDS Malignancy Consortium
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	100
Start date	22 March 2023
Primary completion	30 May 2026
Estimated completion	31 March 2027
Sites	11 locations across United States

Drugs / interventions tested

Computed Tomography
Smoking Cessation Intervention

Conditions studied

HIV Infection — all drugs for HIV Infection →
Tobacco-Related Carcinoma — all drugs for Tobacco-Related Carcinoma →

Sponsor

AIDS Malignancy Consortium

Who can join

Adults 45 to 80, any sex, with HIV Infection or Tobacco-Related Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

HIV and lung cancer: a single cancer center experience.
Palecki J, Tucker M, Bernstein A, Melby G, et al · · 2025 · PMID 41103944 · DOI 10.3389/fonc.2025.1600709

Verify or expand the search:

Other trials of Computed Tomography

Trials testing the same drug.

NCT07229339 — Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07441681 — Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive · Phase 3 · not yet recruiting
NCT07365306 — Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant · Phase 2 · not yet recruiting
NCT07147231 — Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem · Phase 1, PHASE2 · recruiting
NCT07572123 — Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem · Phase 2, PHASE3 · not yet recruiting

Other recruiting trials for HIV Infection

Currently open trials in the same condition.

NCT06900829 — #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-i · NA · recruiting
NCT06908252 — MAPS PrEP Van Study · Phase 4 · recruiting
NCT07042945 — MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003) · Phase 1 · recruiting
NCT06716450 — Multiplo Tp/HIV Self-Test · NA · recruiting
NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting

Other AIDS Malignancy Consortium trials

Trials by the same sponsor.

NCT04142398 — Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men · withdrawn
NCT04142385 — Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men · withdrawn
NCT05077527 — Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · Phase 1 · recruiting
NCT04305691 — Trial of Ixazomib for Kaposi Sarcoma · Phase 2 · recruiting
NCT05510908 — Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04949464 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AIDS Malignancy Consortium
Last refreshed: 23 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04949464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing